NO975322L - Flytende hydrokarbonemulsjon som et vaskulært nitrogenoksydreservoar - Google Patents
Flytende hydrokarbonemulsjon som et vaskulært nitrogenoksydreservoarInfo
- Publication number
- NO975322L NO975322L NO975322A NO975322A NO975322L NO 975322 L NO975322 L NO 975322L NO 975322 A NO975322 A NO 975322A NO 975322 A NO975322 A NO 975322A NO 975322 L NO975322 L NO 975322L
- Authority
- NO
- Norway
- Prior art keywords
- nitric oxide
- liquid hydrocarbon
- hydrocarbon emulsion
- oxide reservoir
- vascular nitric
- Prior art date
Links
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 title abstract 8
- 239000000839 emulsion Substances 0.000 title abstract 3
- 239000007788 liquid Substances 0.000 title abstract 2
- 239000004215 Carbon black (E152) Substances 0.000 title 1
- 229930195733 hydrocarbon Natural products 0.000 title 1
- 150000002430 hydrocarbons Chemical class 0.000 title 1
- 230000002792 vascular Effects 0.000 title 1
- NBVXSUQYWXRMNV-UHFFFAOYSA-N fluoromethane Chemical compound FC NBVXSUQYWXRMNV-UHFFFAOYSA-N 0.000 abstract 2
- 108010054147 Hemoglobins Proteins 0.000 abstract 1
- 102000001554 Hemoglobins Human genes 0.000 abstract 1
- 108010061951 Methemoglobin Proteins 0.000 abstract 1
- 206010057469 Vascular stenosis Diseases 0.000 abstract 1
- 206010047139 Vasoconstriction Diseases 0.000 abstract 1
- 239000008280 blood Substances 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 abstract 1
- 230000007812 deficiency Effects 0.000 abstract 1
- 230000004962 physiological condition Effects 0.000 abstract 1
- 230000025033 vasoconstriction Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0026—Blood substitute; Oxygen transporting formulations; Plasma extender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/02—Halogenated hydrocarbons
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Dermatology (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/501,976 US5726209A (en) | 1995-06-07 | 1995-06-07 | Liquid fluorocarbon emulsion as a vascular nitric oxide reservoir |
| PCT/US1996/009549 WO1996040058A2 (en) | 1995-06-07 | 1996-06-07 | Liquid fluorocarbon emulsion as a vascular nitric oxide reservoir |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO975322D0 NO975322D0 (no) | 1997-11-19 |
| NO975322L true NO975322L (no) | 1998-01-09 |
Family
ID=23995789
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO975322A NO975322L (no) | 1995-06-07 | 1997-11-19 | Flytende hydrokarbonemulsjon som et vaskulært nitrogenoksydreservoar |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US5726209A (ko) |
| EP (1) | EP0831776A2 (ko) |
| JP (1) | JPH11507351A (ko) |
| KR (1) | KR19990022586A (ko) |
| CN (1) | CN1192136A (ko) |
| AU (1) | AU718120B2 (ko) |
| CA (1) | CA2221965A1 (ko) |
| HU (1) | HUP9900900A2 (ko) |
| IL (1) | IL122261A (ko) |
| NO (1) | NO975322L (ko) |
| PL (1) | PL323821A1 (ko) |
| WO (1) | WO1996040058A2 (ko) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5869539A (en) * | 1996-04-17 | 1999-02-09 | Board Of Regents, The University Of Texas System | Emulsions of perfluoro compounds as solvents for nitric oxide (NO) |
| US6103275A (en) * | 1998-06-10 | 2000-08-15 | Nitric Oxide Solutions | Systems and methods for topical treatment with nitric oxide |
| RU2161122C1 (ru) * | 1999-09-10 | 2000-12-27 | Институт молекулярной генетики РАН | Способ ускорения окисления оксида азота (no) в гетерогенной среде |
| JP5781727B2 (ja) * | 2007-02-23 | 2015-09-24 | 株式会社ネクスト２１ | 血管攣縮の治療剤又は予防剤 |
| US8906855B2 (en) | 2007-12-22 | 2014-12-09 | Vivacelle Bio, Inc. | Methods and compositions for treating conditions related to lack of blood supply, shock and neuronal injuries |
| US8618056B2 (en) | 2007-12-22 | 2013-12-31 | Cuthbert O. Simpkins | Methods and compositions for treating conditions related to lack of blood supply, shock and neuronal injuries |
| US20100196461A1 (en) * | 2009-01-30 | 2010-08-05 | Simpkins Cuthbert O | Resuscitation fluid |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4987154A (en) * | 1986-01-14 | 1991-01-22 | Alliance Pharmaceutical Corp. | Biocompatible, stable and concentrated fluorocarbon emulsions for contrast enhancement and oxygen transport in internal animal use |
| US4865836A (en) * | 1986-01-14 | 1989-09-12 | Fluoromed Pharmaceutical, Inc. | Brominated perfluorocarbon emulsions for internal animal use for contrast enhancement and oxygen transport |
| US4927623A (en) * | 1986-01-14 | 1990-05-22 | Alliance Pharmaceutical Corp. | Dissolution of gas in a fluorocarbon liquid |
| US4781676A (en) * | 1987-02-20 | 1988-11-01 | Air Products And Chemicals, Inc. | Interstitial administration of perfluorochemical emulsions for reoxygenation of hypoxic tumor cells |
| US4866096A (en) * | 1987-03-20 | 1989-09-12 | Air Products And Chemicals, Inc. | Stable fluorochemical aqueous emulsions |
| US4895876A (en) * | 1987-03-20 | 1990-01-23 | Air Products And Chemicals, Inc. | Concentrated stable fluorochemical aqueous emulsions containing triglycerides |
| US4993415A (en) * | 1988-08-19 | 1991-02-19 | Alliance Pharmaceutical Corp. | Magnetic resonance imaging with perfluorocarbon hydrides |
| US5536241A (en) * | 1990-12-05 | 1996-07-16 | The General Hospital Corporation | Methods and devices for relaxing smooth muscle contractions |
| WO1993002653A1 (en) * | 1991-08-08 | 1993-02-18 | Segel Leigh D | Fluorocarbon blood substitute |
| US5628930A (en) * | 1992-10-27 | 1997-05-13 | Alliance Pharmaceutical Corp. | Stabilization of fluorocarbon emulsions |
| DE69425331D1 (de) * | 1993-10-08 | 2000-08-24 | Us Health | Verwendung von stickstoffoxid freisetzenden verbindungen als arzneimittel zur strahlungssensibilisation fur hypoxische zellen |
| DE69424560T2 (de) * | 1993-11-02 | 2001-01-18 | The Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College, Baton Rouge | Verwendung von stickstoffoxid freisetzenden verbindungen zur herstellung eines arzneimittels zum schutz gegen die ischämischen reperfusionsschäden |
-
1995
- 1995-06-07 US US08/501,976 patent/US5726209A/en not_active Expired - Fee Related
-
1996
- 1996-06-07 PL PL96323821A patent/PL323821A1/xx unknown
- 1996-06-07 IL IL12226196A patent/IL122261A/en not_active IP Right Cessation
- 1996-06-07 AU AU61615/96A patent/AU718120B2/en not_active Ceased
- 1996-06-07 JP JP9501847A patent/JPH11507351A/ja active Pending
- 1996-06-07 HU HU9900900A patent/HUP9900900A2/hu unknown
- 1996-06-07 KR KR1019970709067A patent/KR19990022586A/ko not_active Application Discontinuation
- 1996-06-07 CN CN96195948A patent/CN1192136A/zh active Pending
- 1996-06-07 EP EP96919220A patent/EP0831776A2/en not_active Ceased
- 1996-06-07 WO PCT/US1996/009549 patent/WO1996040058A2/en active Search and Examination
- 1996-06-07 CA CA002221965A patent/CA2221965A1/en not_active Abandoned
-
1997
- 1997-11-19 NO NO975322A patent/NO975322L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| HUP9900900A2 (hu) | 1999-08-30 |
| MX9709695A (es) | 1998-06-28 |
| EP0831776A2 (en) | 1998-04-01 |
| IL122261A (en) | 2001-09-13 |
| WO1996040058A2 (en) | 1996-12-19 |
| PL323821A1 (en) | 1998-04-27 |
| US5726209A (en) | 1998-03-10 |
| JPH11507351A (ja) | 1999-06-29 |
| AU718120B2 (en) | 2000-04-06 |
| KR19990022586A (ko) | 1999-03-25 |
| NO975322D0 (no) | 1997-11-19 |
| CA2221965A1 (en) | 1996-12-19 |
| IL122261A0 (en) | 1998-04-05 |
| AU6161596A (en) | 1996-12-30 |
| WO1996040058A3 (en) | 1997-02-13 |
| CN1192136A (zh) | 1998-09-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Huggins | Chylothorax and cholesterol pleural effusion | |
| Daram et al. | Nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis: report of a new case with literature review | |
| Ho | Hemodialysis membranes: interleukins, biocompatibility, and middle molecules | |
| Waring et al. | Uric acid as a risk factor for cardiovascular disease | |
| Spiess | Perfluorocarbon emulsions as a promising technology: a review of tissue and vascular gas dynamics | |
| Spiegel et al. | Long‐term effects of magnesium carbonate on coronary artery calcification and bone mineral density in hemodialysis patients: a pilot study | |
| Rinder et al. | Acquired von Willebrand's disease: a concise review | |
| NO20050827L (no) | Anvendelse av interferon-B ved behandling av nyresvikt | |
| MX9801159A (es) | Metodos de reduccion o para mantener los niveles reducidos de lipidos en la sangre usando composiciones de proteina ob. | |
| NO975322L (no) | Flytende hydrokarbonemulsjon som et vaskulært nitrogenoksydreservoar | |
| WO2005013947A3 (en) | Means and methods for treating a disease which is associated with an excess transport of hyaluronan across a lipid bilayer | |
| DE60025008D1 (de) | Bestimmung von adrenomedullin-bindenden proteinen | |
| Pires et al. | Engineering therapeutics to detoxify hemoglobin, heme, and iron | |
| Xiang et al. | Extremity trauma exacerbates acute kidney injury following prolonged hemorrhagic hypotension | |
| WO2022023566A3 (en) | Cd-3 antibodies for the treatment of coronavirus | |
| JP2010530000A (ja) | アタシセプトなどのＴＡＣＩ−Ｉｇ融合タンパク質を用いた自己免疫疾患を治療するための投薬法 | |
| Ivashkova et al. | Bradykinin B2 receptor antagonism with LF 18-1505T reduces brain edema and improves neurological outcome after closed head trauma in rats | |
| Gauthier et al. | Cyclosporine avoidance | |
| Tanaka et al. | In vitro effects of antihypertensive drugs on thromboxane agonist (U46619)-induced vasoconstriction in human internal mammary artery | |
| TAYLOR et al. | Laparoscopic management of gallstone pancreatitis | |
| Pupovac et al. | Factor eight inhibiting bypass activity for refractory bleeding in acute type A aortic dissection repair: A propensity‐matched analysis | |
| Brezis et al. | Nightmares from digoxin | |
| Vasugi et al. | Systemic lupus erythematosis with antiphospholipid antibody syndrome: A mimic of Buerger′ s disease | |
| Den Hollander | New insights in the pathophysiology of burns: implications for the prevention of wound progression: SA Burn Society Congress | |
| WO2002011714A3 (en) | Antagonists of the magnesium binding defect as therapeutic agents and methods for treatment of abnormal physiological states |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |